2 Stocks That Could Grow Your Portfolio Over the Next Decade

These two TSX stocks could be stellar additions to your long-term portfolio, given their multi-year growth potential and discounted stock prices.

| More on:

The sell-off in the equity markets has intensified, with the S&P/TSX Composite Index trading around 13% lower year to date. Multiple rate hikes and the warning by the Chairman of the Federal Reserve of the United States that the central bank could take further actions to stem the rising prices have made investors nervous, leading to a correction.

Meanwhile, technology stocks have witnessed substantial selling over the last few months as investors turned skeptical about their growth potential in this high-interest environment. However, if you are a long-term investor, here are two high-growth stocks you can now buy at a substantial discount.

Docebo

Docebo (TSX:DCBO)(NASDAQ:DCBO) offers cloud-based enterprise learning management system (LMS) platforms to businesses across multiple countries. Although the pandemic accelerated the demand for the company’s products and services, the company has been delivering solid performance since 2016, with its revenue growing at a CAGR (compounded annual growth rate) of 60%. The expansion of its customer base from 900 in 2016 to 2,800 in 2021 and four times growth in its average contract value drove its sales.

Docebo’s growth has continued in 2022, with its revenue and adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) growing by 41.4% and 64.3%, respectively. Over the previous four quarters, the company has added 621 new customers, including several big-ticket clients. Its average contract value has expanded by 18.4% to US$44,500.

Despite the challenging environment, I expect Docebo’s growth to continue due to the expanding addressable market and its growth initiatives. Amid the growing adoption of LMS solutions, Verified Market Research projects the LMS market to grow at a CAGR of 19.1% through 2030. So, with its highly configurable and artificial intelligence-powered LMS platform, Docebo could benefit from market expansion.

However, amid the recent selloff in the tech sector, Docebo has lost over half its stock value this year and trades at an NTM (next 12 months) price-to-sales multiple of 5.2, lower than its historical average. So, considering its growth potential and discounted stock price, I believe Docebo could deliver multi-fold returns in the long term.

Nuvei

Nuvei (TSX:NVEI)(NASDAQ:NVEI), which facilitates digital payments across 200 markets while supporting 570 alternative payment methods (APM), would be my second pick. With its modular, flexible, and scalable platform, the company allows its customers to accept next-generation payment options. Meanwhile, the e-commerce market expanded during the pandemic, thus popularizing digital payments.

Amid the favorable environment, Nuvei continues to deliver impressive performance. In the first six months of this year, its revenue rose 30% amid 40% volume growth, with e-commerce representing 88% of its total volumes. Also, its adjusted EBITDA and EPS (earnings per share) grew by 27% and 22.8%, respectively.

Going forward, I expect the company’s growth to continue as the global digital payments market expands. Markets and Markets projects the global digital payments market to grow at a CAGR of 15.4% through 2026. Currently, the company is focusing on introducing innovative product offerings, expanding geographically, and increasing its APM portfolio to drive growth. Besides, Nuvei’s regulated online gaming vertical, which posted 22% revenue growth in the second quarter, could be a substantial growth driver as more markets legalize gambling.

However, facing weakness in the tech sector, Nuvei has lost over 55% of its stock value this year. The steep correction has dragged its NTM price-to-earnings multiple down to an attractive 14. So, I believe Nuvei could be a worthwhile addition to your long-term portfolio. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei Corporation. The Motley Fool recommends Docebo Inc. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »